Assessing decline: visualising progression in Huntington's disease using a clinical dashboard with Enroll-HD data.
Assessing decline: visualising progression in Huntington's disease using a clinical dashboard with Enroll-HD data.
Background: in Huntington’s disease (HD), it remains unclear how symptom severity and rate of symptomatic change relates to age and CAG repeat number (CAGn). It is often difficult for clinicians to assess whether an affected individual’s symptoms are progressing at a similar rate to their affected peers, limiting their ability to intervene at the most appropriate time.
Objective: to develop a clinical dashboard that compares an individual’s total motor score (TMS), total functional capacity (TFC) and symbol digit modality test (SDMT) scores against a global cohort, controlling for age and CAGn. The dashboard could then be used by clinicians to identify individuals progressing at a disproportionate rate to his or her peers.
Methods: annualised longitudinal clinical assessment scores from the Enroll-HD dataset were used to generate decline trajectories of the global cohort, allowing cross-sectional (TMS n = 734; TFC n = 734; SDMT n = 694) and longitudinal (TMS n = 270; TFC n = 270; SDMT n = 247) comparison with individual clinical symptom rating scores, to assess decline relative to affected peers.
Results: an electronic dashboard with a dynamic output display was created that rapidly compares clinical symptom rating scores of a specific individual against affected peers from a global cohort of comparable CAGn.
Conclusions: this study shows the potential for use of multi-centre trial data in allowing comparison of the individual to a larger group to facilitate improved decision-making for individual patients. Visualisation of these metrics via a clinical dashboard demonstrates how it may aid identification of those with disproportionate decline, offering potential for intervention at specific critical points in the disease course.
139-147
Walker, Thomas
4ad2e691-9a88-4cb1-b4d7-0ec3a4ac33ea
Ghosh, Boyd
f8e37115-eb7a-427b-ad2a-d1d5acb26552
Kipps, Christopher
e43be016-2dc2-45e6-9a02-ab2a0e0208d5
30 June 2017
Walker, Thomas
4ad2e691-9a88-4cb1-b4d7-0ec3a4ac33ea
Ghosh, Boyd
f8e37115-eb7a-427b-ad2a-d1d5acb26552
Kipps, Christopher
e43be016-2dc2-45e6-9a02-ab2a0e0208d5
Walker, Thomas, Ghosh, Boyd and Kipps, Christopher
(2017)
Assessing decline: visualising progression in Huntington's disease using a clinical dashboard with Enroll-HD data.
Journal of Huntington's Disease, 6 (2), .
(doi:10.3233/jhd-170234).
Abstract
Background: in Huntington’s disease (HD), it remains unclear how symptom severity and rate of symptomatic change relates to age and CAG repeat number (CAGn). It is often difficult for clinicians to assess whether an affected individual’s symptoms are progressing at a similar rate to their affected peers, limiting their ability to intervene at the most appropriate time.
Objective: to develop a clinical dashboard that compares an individual’s total motor score (TMS), total functional capacity (TFC) and symbol digit modality test (SDMT) scores against a global cohort, controlling for age and CAGn. The dashboard could then be used by clinicians to identify individuals progressing at a disproportionate rate to his or her peers.
Methods: annualised longitudinal clinical assessment scores from the Enroll-HD dataset were used to generate decline trajectories of the global cohort, allowing cross-sectional (TMS n = 734; TFC n = 734; SDMT n = 694) and longitudinal (TMS n = 270; TFC n = 270; SDMT n = 247) comparison with individual clinical symptom rating scores, to assess decline relative to affected peers.
Results: an electronic dashboard with a dynamic output display was created that rapidly compares clinical symptom rating scores of a specific individual against affected peers from a global cohort of comparable CAGn.
Conclusions: this study shows the potential for use of multi-centre trial data in allowing comparison of the individual to a larger group to facilitate improved decision-making for individual patients. Visualisation of these metrics via a clinical dashboard demonstrates how it may aid identification of those with disproportionate decline, offering potential for intervention at specific critical points in the disease course.
This record has no associated files available for download.
More information
Published date: 30 June 2017
Identifiers
Local EPrints ID: 489349
URI: http://eprints.soton.ac.uk/id/eprint/489349
PURE UUID: 69f89515-c6e6-43e2-bd58-7e286bed19c1
Catalogue record
Date deposited: 22 Apr 2024 16:37
Last modified: 21 Sep 2024 01:58
Export record
Altmetrics
Contributors
Author:
Thomas Walker
Author:
Boyd Ghosh
Author:
Christopher Kipps
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics